Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.77
+0.14 (0.96%)
At close: Aug 13, 2025, 4:00 PM
14.83
+0.06 (0.41%)
Pre-market: Aug 14, 2025, 9:09 AM EDT
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $46.31 billion as of August 14, 2025. Its market cap has increased by 7.73% in one year.
Market Cap
46.31B
Enterprise Value
78.18B
1-Year Change
7.73%
Ranking
Category
Stock Price
$14.77
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $46.31B, a decrease of -34.96%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 46.14B | 9.53% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |